|
| Health parameters (reference range) | Parameters of patient | Expected toxic consequences of inhalant abuse |
|
| Complete blood count | | |
| Red blood cell (4.3–5.7 × 106 μL) | 5.04 | High red blood cell count |
| White blood cell (4.5–11.0 × 103 μL) | 7.41 | High hemoglobin level |
| Platelet (150–450 × 103 μL) | 307 | Aplastic anemia |
| Hemoglobin (13.2–17.3 g/dL) | 15 | Leukemia |
| Hematocrit (39–49%) | 44.2 | |
| Liver function tests | | |
| Aspartate transaminase (<35 U/L) | 18 | High levels of transaminases |
| Alanine transaminase (<45 U/L) | 24 | |
| Gamma-glutamyl transferase (<55 U/L) | 31 | |
| Total protein (6.4–8.3 g/dL) | 6.7 | |
| Albumin (3.5–5.2 g/dL) | 4.5 | |
| Kidney function tests | | |
| Urea (10–50 mg/dL) | 31 | High levels of kidney function tests |
| Uric acid (3.5–7.2 mg/dL) | 4.9 | Nephritis |
| Creatinine (0.7–1.3 mg/dL) | 0.93 | Nephrosis |
| | | Tubular necrosis |
| Cranial and cranial diffusion MRI* | Normal MRI findings, right maxillary sinus retention cyst | White matter degeneration
Abnormalities in thalamus, basal ganglia, pons, and cerebellum |
| Neurocognitive tests (age and education adjusted reference scores) | | |
| MMSE score** (>23) | 30 | Dementia |
| Wechsler Memory Scale subtests | | Cognitive deficits on memory, attention, problem solving, learning, and visual-motor coordination |
| Digit-span forward (>4,72 1,46) | 6 |
| Digit-span backward (>4,97 1,53) | 5 |
| Stroop test (max. 50 seconds) | 21 | |
| Verbal fluency test (40 12) | 40 | |
| Cardiologic evaluation | | |
| Electrocardiography (ECG) | Normal sinus rhythm with the heart rate of 89/minute |
Sudden sniffing death syndrome
Cardiomyopathy
Arrhythmias
Myocardial infarction |
| Holter ECG | Rare ventricular and supraventricular extrasystoles |
| Echocardiography | Normal echocardiographic findings |
|
